Economics of cancer for policy

Contact us
Get in touch with our policy team to find out more information about our work and our policies.
Cancer is the defining health issue of our time. Beyond the enormous emotional and physical toll for patients and families, cancer has also important economic implications. With cancer cases growing and budgets tightening, there is a pressing need to prioritise resources and transform cancer outcomes through investment in prevention, early detection and research.
The economic impact of cancer
Our work sheds light on the wider economic and societal impact of cancer beyond the human cost of pain and suffering. These include healthcare costs, other non-medical costs like travel costs, informal care borne by people affected by cancer and their families and costs related to reduced paid and unpaid work. The latter, usually referred to as productivity losses, can be the results of a cancer diagnosis or premature mortality.
The economic loss of cancer mortality

The UK economy loses around £10.3 billion each year in lost productivity due to premature mortality from cancer, more than any other disease.
This graph shows the economic losses associated with different causes of death, based on the estimated lifetime economic contribution individuals would have made had their lives not been cut short.
Cancer is the leading cause of economic loss due to mortality, not only because it’s the biggest cause of death in the UK but also because it affects people of all ages.
Cost of Cancer in the UK
The evidence on the wide-ranging economic impact of cancer is summarised in a report developed with the University of Leeds. This also identifies important evidence gaps – including how costs vary by age, socio-economic status, ethnicity and cancer stage, as well as the financial impact experienced by people affected by cancer.
Read more
Visit our Cancer News site to read more about the cost of cancer and its impact on the economy: